Abstract

The majority of existing high-power laser therapeutic instruments employ a single wavelength for a single target; thus, they do not meet the requirements for clinical treatment. Therefore, this study designs an optical system for a dual-wavelength high-power laser therapeutic device with a variable spot size. The waist of the short arm of the optical cavity and the G1G2 parameter (G-parameter equivalent cavity method) is calculated using MATLAB software, the spot size and divergence angle on the lens are calculated using an ABCD matrix, and the distance between the treatment spot at different spot sizes and the transformation lens is calculated in order to design the treatment handpiece. Experiments are conducted to analyze the stability at an output power of 532 nm before beam combination and the power loss after beam combination. The results show that the output power stability of the 532-nm beam varies by less than 2% over 150 min, and the loss of both wavelengths is less than 20%, which meets the clinical requirements of the system. The safety performance can meet the requirements of national general standards for medical electrical safety. The proposed dual-wavelength laser therapy instrument has both visible wave and near-infrared wave characteristics; thus, it can accurately target both superficial vessels and vessels with a larger diameter and deeper position. This therapeutic device has the advantages of simple operation, stable and reliable laser output, high security and strong anti-interference ability, and meets the comprehensive clinical treatment demands of vascular diseases.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.